These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24473349)

  • 21. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.
    Feng JQ; Clinkenbeard EL; Yuan B; White KE; Drezner MK
    Bone; 2013 Jun; 54(2):213-21. PubMed ID: 23403405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia].
    Kinoshita Y; Fukumoto S
    Clin Calcium; 2014 Aug; 24(8):1217-22. PubMed ID: 25065874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [FGF23 and skeletal metabolism].
    Michigami T
    Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphate wasting and fibroblast growth factor-23.
    Nanes MS
    Curr Opin Endocrinol Diabetes Obes; 2013 Dec; 20(6):523-31. PubMed ID: 24157604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
    Kinoshita Y
    Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone as a source of FGF23: regulation by phosphate?
    Mirams M; Robinson BG; Mason RS; Nelson AE
    Bone; 2004 Nov; 35(5):1192-9. PubMed ID: 15542045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approach to Hypophosphatemic Rickets.
    Ackah SA; Imel EA
    J Clin Endocrinol Metab; 2022 Dec; 108(1):209-220. PubMed ID: 35981346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice.
    Courbon G; Kentrup D; Thomas JJ; Wang X; Tsai HH; Spindler J; Von Drasek J; Ndjonko LM; Martinez-Calle M; Lynch S; Hivert L; Wang X; Chang W; Feng JQ; David V; Martin A
    JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37943605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report.
    Toi N; Imanishi Y; Nagata Y; Kurajoh M; Morioka T; Shoji T; Shinto Y; Emoto M
    Endocr J; 2023 Apr; 70(4):419-426. PubMed ID: 36575021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.
    Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T
    Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phosphatonin].
    Endo I; Matsumoto T
    Clin Calcium; 2007 Oct; 17(10):1580-4. PubMed ID: 17906412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging topics in pediatric bone and mineral disorders 2008.
    McKay CP; Portale A
    Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF23 and Hypophosphatemic Rickets/Osteomalacia.
    Takashi Y; Kawanami D; Fukumoto S
    Curr Osteoporos Rep; 2021 Dec; 19(6):669-675. PubMed ID: 34755323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathophysiology of hypophosphatemia.
    Ito N; Hidaka N; Kato H
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phosphate metabolism and iron deficiency].
    Yokoyama K
    Clin Calcium; 2016 Feb; 26(2):241-9. PubMed ID: 26813504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone and Nutrition. The relationship between iron and phosphate metabolism].
    Takashi Y; Fukumoto S
    Clin Calcium; 2015 Jul; 25(7):1037-42. PubMed ID: 26119317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.